Rxsight Inc
NASDAQ:RXST
Rxsight Inc
NASDAQ:RXST
Price:
61.68 USD
3.44%
Market Closed
Updated:
May 5, 2024
Section:
Relative Value
The Relative Value of one
RXST
stock under the Base Case scenario is
14.46
USD.
Compared to the current market price of 61.68 USD,
Rxsight Inc
is
Overvalued by 77%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RXST
Relative Value
Base Case
14.46
USD
Overvaluation 77%
Valuation Multiples
Multiples Across Competitors
RXST Competitors Multiples
Rxsight Inc Competitors
Rxsight Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Rxsight Inc
NASDAQ:RXST
|
2.2B USD | 25 | -45.9 | -45.9 | -42 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.4T JPY | 8.5 | 38.3 | 23.2 | 28.7 | |
| CH |
|
Alcon AG
SIX:ALC
|
35.6B CHF | 4.2 | 40.4 | 18 | 36.6 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
193.3B DKK | 7.7 | 39.7 | 26.1 | 30.3 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
21.7B USD | 5.5 | 46.9 | 25.8 | 31.3 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
18B USD | 4.9 | 61.9 | 22.7 | 38.5 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.3T KRW | 310 | -70.3 | -114.6 | -105.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
55.6B CNY | 14.1 | 33.6 | 29.2 | 29.2 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 3.1 | 51.1 | 46.8 | 50.9 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 1.5 | -44.4 | 11.5 | 24.7 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.2B USD | 4 | 15.8 | 11.6 | 13.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
